DigestRedComo funciona
Red
/
Empresas
No
No verificado

Novo Nordisk A/S

Sobre qué escribimos

FarmacéuticaFinanzasGestión empresarial/Administración de EmpresasPolítica InternacionalPublicidad/Marketing/Medios de comunicación/Comunicación

61 Comunicados de prensa

Ver todos los comunicados de prensa
25/11/2025
Farmacéutica
Política Internacional
Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
24/11/2025
Farmacéutica
Política Internacional
Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
14/11/2025
Farmacéutica
Política Internacional
Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
13/11/2025
Farmacéutica
Política Internacional
Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
06/11/2025
Farmacéutica
Política Internacional
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
05/11/2025
Farmacéutica
Medicina Salud Bienestar
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
04/11/2025
Farmacéutica
Gestión empresarial/Administración de Empresas
Anuncios breves
Política Internacional
Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
30/10/2025
Farmacéutica
Política Internacional
Novo Nordisk submits proposal to acquire Metsera, Inc.
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
21/10/2025
Farmacéutica
Política Internacional
Notice convening an Extraordinary General Meeting of Novo Nordisk A/S
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0
21/10/2025
Farmacéutica
Política Internacional
Novo Nordisk announces an Extraordinary General Meeting to be convened to elect new members of the Board of Directors
Fuente
Novo Nordisk A/S
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0